doctitl prospect grant partial exclus licens inhibit cell prolifer use antisens oligonucleotid doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari notic accord 35 u c 209 c 1 37 cfr 404 7 1 nation institut health nih depart health human servic contempl grant partial exclus world wide licens practic invent embodi u patent applic sn 07 821 415 08 187 785 entitl inhibit cell prolifer use antisens oligonucleotid lynx therapeut inc hayward california genta incorpor san diego california jointli cv therapeut inc mountain view california patent right invent assign unit state america prospect partial exclus licens royalti bear compli term condit 35 u c 209 37 cfr 404 7 prospect partial exclus licens may grant unless within 60 day date publish notic nih receiv written evid argument establish grant licens would consist requir 35 u c 209 37 cfr 404 7 patent applic disclos novel strategi use antisens oligonucleotid prevent renarrow heart valv peripher vessel e restenosi follow coronari balloon angioplasti antisens oligonucleotid employ inhibit prolifer smooth muscl cell smc caus restenosi target specif mrna encod certain cell cycl regulatori protein oligonucleotid deliv local via slow biodegrad polym satur antiprolif compound summari address address request copi patent applic inquiri comment materi relat contempl licens direct mr arthur j cohn esq technolog licens specialist offic technolog transfer nation institut health 6011 execut boulevard suit 325 rockvil maryland 208923804 telephon 301 4967735 ext 284 facsimil 301 4020220 sign confidenti agreement requir receiv copi patent applic applic licens field use file respons notic treat object grant contempl licens written comment applic licens receiv nih within sixti 60 day notic consid date august 9 1994 address signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9419937 file 81594 8 45 frfile bill bill code 414001p bill